logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies

Apr 26, 2017

RISE Life Science Corp (CSE:RLSC) (formerly Luminor Medical CSE: LMT)

Luminor Medical Announces Change in Auditor

Mar 18, 2017

Zecotek Photonics Inc TSXV:ZMS

Shanghai EBO Optoelectronics Company to Exclusively use Zecotek LFS Scintillation Crystals in China

Mar 9, 2017

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Signs Two Key Service Partnerships for Final Prototype Manufacturing and Testing of its Dermal Injector

Mar 1, 2017

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces European Patents for its Innovative Dermal Injector Technologies

Feb 10, 2017

RISE Life Science Corp (CSE:RLSC) (formerly Luminor Medical CSE: LMT)

Luminor Medical Completes Private Placement

Jan 11, 2017

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel CEO Provides 2017 Forecast

Jan 5, 2017

Zecotek Photonics Inc TSXV:ZMS

ZECOTEK CLOSES NON-BROKERED PRIVATE PLACEMENT

Nov 18, 2016

Zecotek Photonics Inc TSXV:ZMS

ZECOTEK CLOSES NON-BROKERED PRIVATE PLACEMENT

Aug 29, 2016

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces CEO Update

Feb 17, 2016

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Receives European Patent for its Innovative Dermal Injector Technology

Jan 12, 2016

  • ‹‹ Previous
  • 86
  • 87
  • 88
  • 89
  • 90

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada